Vanguard Capital Management
KURA icon

Vanguard Capital Management’s Kura Oncology KURA Stock Holding History

Vanguard Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43M Buy
3,916,164
+130,479
+3% +$1.23M ﹤0.01% 2028
2026
Q1 		$30.8M Buy
+3,785,685
New +$32.5M ﹤0.01% 2109

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Vanguard Capital Management's KURA Position: Q2 2026 in Review

Vanguard Capital Management increased its Kura Oncology (KURA) stake by 3.4% in Q2 2026, buying an estimated $1.23M and bringing the position to 3,916,164 shares worth $43M. The position accounts for ﹤0.01% of the portfolio, ranked #2028.

Vanguard Capital Management first reported a position in KURA in Q1 2026 and has held it in 2 quarters since. 219 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Vanguard Capital Management held 3,916,164 shares of Kura Oncology worth $43M as of Q2 2026.
  • Vanguard Capital Management bought 130,479 Kura Oncology shares in Q2 2026, an estimated $1.23M.
  • Kura Oncology made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2028 holding.
  • Vanguard Capital Management first reported a position in Kura Oncology in Q1 2026 and has held it in 2 quarters since.
  • 219 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.